AMRX Stock Advances As Generic To Ipsen’s Hormone Shot Gets FDA Nod
The Food and Drug Administration (FDA) cleared a 120-milligram prefilled syringe that copies Ipsen’s Somatuline Depot, a long-acting under-the-skin injection. Ipsen’s Somatuline Depot booked $983 million in U.S. sales in the year through July, according to IQVIA. The agency also granted Competitive Generic Therapy status, a label meant to speed copies of drugs that still … Read more